Organic compounds

Details for Australian Patent Application No. 2008335811 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Li, Peng

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008335811

PCT Pub. Number WO2009/075784

Priority 61/012,040 06.12.07 US

Filing date 6 December 2008

Wipo publication date 18 June 2009

Acceptance publication date 17 May 2012

International Classifications

C07D 487/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/505 (2006.01) - Pyrimidines

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/075784 Priority application(s): WO2009/075784

22 March 2012 Assignment before Grant

  Intra-Cellular Therapies, Inc. The application has been assigned to Takeda Pharmaceutical Company Limited 2009

17 May 2012 Application Accepted

  Published as AU-B-2008335811

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008335819-Trap for bed bugs and the like

2008335809-Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition